Paul Graham Fisher
Academic Appointments
- Professor - Med Center Line, Neurology & Neurological Sciences
- Professor - Med Center Line, Pediatrics
- Professor - Med Center Line (By courtesy), Neurosurgery
- Member, Cancer Center
Contact Information
-
Clinical Offices
Pediatric Oncology Clinic 725 Welch Rd Palo Alto, CA 94304 Tel Work (650) 497-8953 Fax (650) 497-8101Practices at Stanford Hospital and Clinics and Lucile Packard Children's Hospital
- Academic Offices
Personal Information EmailAdministrative Contact Gayla Weng Administrative Assistant Email Tel Work 650-721-5889Not for medical emergencies or patient use
Professional Snapshot
Clinical Focus
- Cancer> Neuro Oncology
- Neurology - Child Neurology
- Neuro-Oncology
- Neurology
Administrative Appointments
- Chief, Division of Child Neurology, Department of Neurology (2008 - present)
Professional Education
| Fellowship: | The Children's Hospital of Philadelphia, PA (1995) |
| Residency: | Johns Hopkins University, MD (1994) |
| Residency: | Johns Hopkins University, MD (1991) |
| Internship: | Johns Hopkins University, MD (1990) |
| Medical Education: | UCSF School of Medicine, CA (1989) |
Graduate & Fellowship Program Affiliations
Industry Relationships
Stanford is committed to ethical and transparent interactions with our industry partners. It is our policy to disclose payments of $5,000 or more, equity valued at $5,000 or more in a publicly traded company, or any equity in a privately held company, to physicians and scientists employed by Stanford University from companies or other commercial entities with which they interact as part of their professional activities. View Full Information
| Consulting: | Enzon Pharmaceticals |
Scientific Focus
Current Research Interests
Clinical neuro-oncology: My research explores the epidemiology, natural history, and disease patterns of brain tumors in childhood, as well as prospective clinical trials for treating these neoplasms. Research interests also include neurologic effects of cancer and its therapies, and childhood headaches.
Clinical Trials
- Low-Dose Radiation Therapy and Combination Chemotherapy Following Surgery in Treating Children With Newly Diagnosed Primitive Neuroectodermal Tumor or Medulloblastoma Recruiting
- Phase 2 Study of Nimotuzumab in Pediatric Recurrent Diffuse Intrinsic Pontine Glioma Recruiting
- Intrathecal and Systemic Chemotherapy Combined With Radiation Therapy in Treating Young Patients With Newly Diagnosed Central Nervous System Atypical Teratoid/Rhabdoid Tumors Completed
- PI EGFRvIII Peptide Vaccination after Radiation in Children w/ Diffuse Intrinsic Pontine Gliomas Not yet recruiting
- An Open-Labeled, Extended-Use of XERECEPT (hCRF) for Patients in Studies NTI 0302, 0303, or Other Designated Studies Completed
Publications
- Oncogenic BRAF mutation with CDKN2A inactivation is characteristic of a subset of pediatric malignant astrocytomas. Cancer Res. 2010; (2): 512-9
- Both location and age predict survival in ependymoma: a SEER study. Pediatr Blood Cancer. 2009; (1): 65-9
- Incidence patterns for ependymoma: a surveillance, epidemiology, and end results study. J Neurosurg. 2009; (4): 725-9
- Do children and adults differ in survival from medulloblastoma? A study from the SEER registry. J Neurooncol. 2009; (1): 81-5
- Cerebrovascular disease in childhood cancer survivors: A Children's Oncology Group Report. Neurology. 2009; (22): 1906-13
Help